MULTIPARTICULATE ORAL DOSAGE FORM PROVIDING PROLONGED RELEASE OF TAPENTADOL

The invention relates to an oral pharmaceutical dosage form comprising a plurality of coated particles, wherein said coated particles comprise a core which comprises a Tapentadol component and which is coated with a controlled release coating material, wherein the controlled release coating material...

Full description

Saved in:
Bibliographic Details
Main Authors BERTRAM, Ulrike, PHILIPP, Anika-Anina, POELLINGER, Norbert, PRANGE, Wolfgang, SCHILLER, Marc, GRAVE, Annette, REINHOLD, Ulrich, STRAUB, Stefanie
Format Patent
LanguageEnglish
French
German
Published 08.04.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to an oral pharmaceutical dosage form comprising a plurality of coated particles, wherein said coated particles comprise a core which comprises a Tapentadol component and which is coated with a controlled release coating material, wherein the controlled release coating material comprises a lubricant component and a polymer component, wherein the polymer component comprises one or more cellulose ethers and/or one or more acrylates, and wherein the pharmaceutical dosage form provides controlled release of the Tapentadol component.
Bibliography:Application Number: EP20180727301